160
Participants
Start Date
April 30, 2018
Primary Completion Date
December 3, 2020
Study Completion Date
December 3, 2020
Turoctocog alfa pegol
Turoctocog alfa pegol 75 IU/kg body weight will be administered once weekly as intravenous injections for a duration of 2 years.
Turoctocog alfa pegol
Turoctocog alfa pegol 60 IU/kg body weight (for patients younger than 12 years) and 50 IU/kg body weight (for patients, 12 years or older) will be administered twice weekly as intravenous injections for a duration of 2 years.
Turoctocog alfa pegol
Turoctocog alfa pegol 50 IU/kg body weight will be administered three times weekly as intravenous injections for a duration of 2 years.
Novo Nordisk Investigational Site, Taipei
Novo Nordisk Investigational Site, Lausanne
Novo Nordisk Investigational Site, Camperdown
Novo Nordisk Investigational Site, Parkville
Novo Nordisk Investigational Site, Debrecen
Novo Nordisk Investigational Site, Bellinzona
Novo Nordisk Investigational Site, Zurich
Novo Nordisk Investigational Site, Zurich
Novo Nordisk Investigational Site, Århus N
Novo Nordisk Investigational Site, Berlin
Novo Nordisk Investigational Site, New Hyde Park
Novo Nordisk Investigational Site, Philadelphia
Novo Nordisk Investigational Site, Milan
Novo Nordisk Investigational Site, Baltimore
Novo Nordisk Investigational Site, Norfolk
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Charlotte
Novo Nordisk Investigational Site, Málaga
Novo Nordisk Investigational Site, Charleston
Novo Nordisk Investigational Site, Bornova-IZMIR
Novo Nordisk Investigational Site, Daejeon
Novo Nordisk Investigational Site, Vicenza
Novo Nordisk Investigational Site, İzmit
Novo Nordisk Investigational Site, Nantes
Novo Nordisk Investigational Site, Cincinnati
Novo Nordisk Investigational Site, Dayton
Novo Nordisk Investigational Site, Detroit
Novo Nordisk Investigational Site, East Lansing
Novo Nordisk Investigational Site, Iowa City
Novo Nordisk Investigational Site, Tel Litwinsky
Novo Nordisk Investigational Site, Samsun
Novo Nordisk Investigational Site, Minneapolis
Novo Nordisk Investigational Site, Frankfurt/M.
Novo Nordisk Investigational Site, Homburg
Novo Nordisk Investigational Site, Selangor Darul Ehsan
Novo Nordisk Investigational Site, Bron
Novo Nordisk Investigational Site, Houston
Novo Nordisk Investigational Site, Lviv
Novo Nordisk Investigational Site, Long Beach
Novo Nordisk Investigational Site, Le Kremlin-Bicêtre
Novo Nordisk Investigational Site, Portland
Novo Nordisk Investigational Site, Phoenix
Novo Nordisk Investigational Site, New Orleans
Novo Nordisk Investigational Site, Nashville
Novo Nordisk Investigational Site, Campinas
Novo Nordisk Investigational Site, Toronto
Novo Nordisk Investigational Site, Zagreb
Novo Nordisk Investigational Site, Athens
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Kitakyusyu-shi, Fukuoka
Novo Nordisk Investigational Site, Nara
Novo Nordisk Investigational Site, Tokyo
Novo Nordisk Investigational Site, Vilnius
Novo Nordisk Investigational Site, Groningen
Novo Nordisk Investigational Site, Rotterdam
Novo Nordisk Investigational Site, Oslo
Novo Nordisk Investigational Site, Porto
Novo Nordisk Investigational Site, San Juan
Novo Nordisk Investigational Site, Adana
Novo Nordisk Investigational Site, Antalya
Novo Nordisk Investigational Site, Basingstoke
Novo Nordisk Investigational Site, Cardiff
Novo Nordisk Investigational Site, London
Novo Nordisk Investigational Site, London
Novo Nordisk Investigational Site, Oxford
Novo Nordisk Investigational Site, Oxford
Novo Nordisk Investigational Site, Sheffield
Lead Sponsor
Novo Nordisk A/S
INDUSTRY